Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Articles

Belumosudil: A Rising Star for the Management of Chronic Graft-Versus-Host Disease and the First FDA-Approved ROCK2 Inhibitor

Tony J. Kurian, MD, Frederick Locke, MD

The Hematologist (2021) 18 (6)

https://doi.org/10.1182/hem.V18.6.202168

Published: 2021